Michael Michael

<i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib

Jochen K. Lennerz, Eunice L. Kwak, A. B. Ackerman et al. · Journal of Clinical Oncology · 2011 · 430 citations · Full text

Medicine, Molecular Biology, Oncology +17

Adjunctive Systemic Hyperbaric Oxygen Therapy in Treatment of Severe Prevalently Ischemic Diabetic Foot Ulcer: A randomized study

Ezio Faglia, Favales Favales, Aldeghi Aldeghi et al. · Diabetes Care · 1996 · 392 citations

Health Professions, Surgery, Diabetic Foot Care +15

TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG

Trevor Leong, B. Mark Smithers, Karin Haustermans et al. · Annals of Surgical Oncology · 2017 · 243 citations

Medicine, Oncology, Surgery +15

Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers

Oliver Klein, Damien Kee, Adnan Nagrial et al. · JAMA Oncology · 2020 · 229 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy

Vignesh Narasimhan, Josephine A. Wright, Michael Churchill et al. · Clinical Cancer Research · 2020 · 181 citations · Full text

Pharmacy, Oncology, Pharmacology +15